Patents by Inventor Kerry Klussman

Kerry Klussman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230270877
    Abstract: Provided herein are methods of treating cancer with an antibody that binds an immune cell engager in combination with an antibody-drug conjugate.
    Type: Application
    Filed: April 28, 2023
    Publication date: August 31, 2023
    Applicant: Seagen Inc.
    Inventors: Shyra Gardai, Alyson Smith, Kerry Klussman, Bernard Liu, Heather Van Epps
  • Publication number: 20050123536
    Abstract: The present invention relates to methods for the treatment of immunological disorders other than cancer, comprising administering proteins characterized by their ability to bind to CD30 and exert a cytostatic or cytotoxic effect on an activated lymphocyte. Such proteins include monoclonal antibodies AC10 and IleFi1. AC10 and HeFi-1 derivatives, and antibodies that compete with AC10 and HeFi-1 for binding to CD30. Other such proteins include multivalent anti-CD30 antibodies and anti-CD30 antibodies conjugated to cytotoxic agents. Treatment modalities with antibodies of the invention are also provided.
    Type: Application
    Filed: November 20, 2002
    Publication date: June 9, 2005
    Inventors: Che-Leung Law, Kerry Klussman, Alan Wahl, Peter Senter, Svetlana Doronina, Brian Toki